Budapest, Hungary

Anna Kassainee Zieger


Average Co-Inventor Count = 15.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Anna Kassainee Zieger

Introduction

Anna Kassainee Zieger, a talented inventor based in Budapest, Hungary, has made significant strides in the field of pharmaceuticals. Her work, particularly in neuroleptic actions, demonstrates a commitment to advancing medical science through innovative research and development.

Latest Patents

Anna has been granted a patent for her invention relating to pharmaceutical compositions with neuroleptic action. The patent describes compositions containing 2-halo-6-methyl-9-ergolene derivatives, wherein X can be a chlorine, bromine, or iodine atom, including their acid addition salts. This breakthrough indicates Anna's ability to explore and enhance the efficacy of therapeutic compositions for neurological applications.

Career Highlights

Anna Kassainee Zieger is currently associated with Richter Gedeon Vegyeszeti Gyar Rt., a prominent pharmaceutical company. Her work there emphasizes her role in developing innovative drugs and advancing pharmaceutical formulations that can greatly impact patient care. With one patent to her name, her contributions are already noteworthy, and they may set the foundation for future research and innovations within the industry.

Collaborations

Throughout her career, Anna has collaborated with notable coworkers, including Gabor Megyeri and Tibor Keve. These partnerships highlight the importance of teamwork in the innovation process, bringing together diverse expertise and perspectives to create effective solutions in the pharmaceutical landscape.

Conclusion

Anna Kassainee Zieger's contributions to the field of pharmaceuticals underline her dedication to innovation in medical science. With her patented invention and collaborative efforts, she embodies the spirit of progress in developing neuroleptic treatments that can potentially benefit many individuals. As she continues her work at Richter Gedeon Vegyeszeti Gyar Rt., Anna's future endeavors will undoubtedly be worth following in the world of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…